Topic: Life Sciences & Medicine

  • News

    Foyer Group supports Uni.lu research with a donation of 100000 €

    In a context marked by the COVID-19 crisis, Foyer Group made several donations totalling €100,000 to the holders of four research projects at the University of Luxembourg. Due to exceptional health circumstances, the traditional cheque handover reception could not take place, but the Foyer management and the University representatives promised to keep in touch, in…

    Learn more
  • News

    New study highlights links between inflammation & Parkinson’s disease

    An international collaboration involving researchers from the Luxembourg Centre for Systems Biology (LCSB) at the University of Luxembourg established an association between inflammation and specific genetic mutations in Parkinson’s patients. The study, recently published in the scientific journal Brain, highlights two biomarkers that could be used to assess Parkinson’s disease state and progression. The results…

    Learn more
  • News

    New approach against Parkinson’s disease through stem cell research

    In a seven-year research effort, an international team of scientists has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments. The interdisciplinary research team, led by Prof. Rejko Krüger, of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, experimented on patient-based cell cultures in…

    Learn more
  • News

    EU Commission approved European Space University for Earth & Humanity

    The University of Luxembourg is a partner in the project “European University – European Space University for Earth and Humanity” (UNIVERSEH), approved by the European Commission under the Erasmus+ programme.

    Learn more
  • News

    University’s supercomputer supports fight against COVID-19

    The University’s High-Performance Computing (HPC) facility has significantly contributed to the fight against the COVID-19 pandemic since mid-March 2020.

    Learn more
  • News

    Survival prediction in patients with severe COVID-19 infection

    Taking advantage of a long-standing collaboration with the Wuhan University of Science and Technology, researchers from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg conducted a study based on blood samples from Chinese COVID-19 patients. They developed machine learning tools to identify crucial biomarkers of disease severity. Their results, recently published…

    Learn more
  • News

    First results of the CON-VINCE study

    CON-VINCE, a national research project aiming to evaluate the prevalence and dynamics of the spread of the COVID-19 disease within the Luxembourgish population, was launched at the beginning of April under the umbrella of the Research Luxembourg COVID-19 Task Force. Following the successful recruitment and first testing effort of more than 1800 participants over the…

    Learn more
  • News

    COVID-19 Disease Map: LCSB researchers coordinate international effort

    In the fight against the current pandemic, researchers of the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg are coordinating an international collaboration to build a COVID-19 Disease Map: a comprehensive repository incorporating all current knowledge on the virus-host interaction mechanisms. This online tool will support research and improve our understanding of…

    Learn more
  • News

    Predi-COVID: Predicting the severity of COVID-19 infection

    The Research Luxembourg COVID-19 task force announces the start of “Predi-COVID1”, a study that aims to identify important risk factors and biomarkers associated with COVID-19 severity and long-term health consequences of the disease in Luxembourg. Predi-COVID will contribute to better understanding why some patients infected by SARS-CoV-2 develop severe symptoms while others present only mild…

    Learn more